Mushroom Ingestion Study
1 other identifier
interventional
7
1 country
1
Brief Summary
The investigators propose to determine the effect of consuming 0, 1 or 2 servings of white button (Agaricus bisporus; most popular, lower ergothioneine) or yellow oyster (Pleurotus citrinopileatus; higher ergothioneine) mushrooms on postprandial changes in plasma levels and urinary excretions of mushroom-specific compounds.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2019
CompletedFirst Posted
Study publicly available on registry
February 5, 2020
CompletedStudy Start
First participant enrolled
August 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 21, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 21, 2021
CompletedFebruary 16, 2024
February 1, 2024
9 months
December 18, 2019
February 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change in plasma glucose
Plasma will be assessed for glucose values prior to salad consumption and in response to the test day meal
5 hours
Change in plasma insulin
Plasma will be assessed for insulin values prior to salad consumption and in response to the test day meal
5 hours
Plasma metabolomics
Plasma will be assessed for metabolomics (i.e. ergothioneine) via reverse phase liquid chromatography/mass spectrometry
5 hours
Plasma ergothioneine
Plasma will be assessed for ergothioneine concentration, a compound unique to mushrooms
5 hours
Plasma triglycerides
Plasma will be assessed for triglyceride values at the time of salad consumption and at each hour for 5 hours after salad consumption
5 hours
Study Arms (5)
Control -- no mushrooms
ACTIVE COMPARATORSubjects will be randomized to consume a test day salad with 0 g, 84 g (yellow oyster or white button) or 168 g (yellow or white button) mushrooms. Mushrooms will be cooked prior to serving.
Yellow Oyster -- 84 g
EXPERIMENTALSubjects will be randomized to consume a test day salad with 0 g, 84 g (yellow oyster or white button) or 168 g (yellow or white button) mushrooms. Mushrooms will be cooked prior to serving.
Yellow Oyster -- 168 g
EXPERIMENTALSubjects will be randomized to consume a test day salad with 0 g, 84 g (yellow oyster or white button) or 168 g (yellow or white button) mushrooms. Mushrooms will be cooked prior to serving.
White button -- 84 g
EXPERIMENTALSubjects will be randomized to consume a test day salad with 0 g, 84 g (yellow oyster or white button) or 168 g (yellow or white button) mushrooms. Mushrooms will be cooked prior to serving.
White button 168 g
EXPERIMENTALSubjects will be randomized to consume a test day salad with 0 g, 84 g (yellow oyster or white button) or 168 g (yellow or white button) mushrooms. Mushrooms will be cooked prior to serving.
Interventions
Participants will consume the standardized test day salad plus 84 g (raw weight) mushrooms. Mushrooms will be cooked prior to being served
Participants will consume the standardized test day salad plus 168 g (raw weight) mushrooms. Mushrooms will be cooked prior to being served
Participants will consume the standardized test day salad plus 84 g (raw weight) mushrooms. Mushrooms will be cooked prior to being served
Participants will consume the standardized test day salad plus 168 g (raw weight) mushrooms. Mushrooms will be cooked prior to being served
Eligibility Criteria
You may qualify if:
- Male or female;
- age 30-69 y;
- BMI: 25.0-34.9 kg/m2;
- Not severely or extremely depressed (Beck's Depression Inventory score ≤30)
- Total cholesterol \<240 mg/dL, low-density lipoprotein cholesterol \<160 mg/dL, triglycerides \<400 mg/dL, fasting glucose \<110 mg/dL;
- Systolic/diastolic blood pressure \<140/90 mm Hg;
- Body weight stable for 3 months prior (± 3 kg);
- Stable physical activity regimen 3 months prior;
- Medication use stable for 6 months prior;
- Non-smoking;
- Non-diabetic;
- Not acutely ill;
- Females not pregnant or lactating;
- Participants must be willing and able to consume the prescribed diets and travel to testing facilities.
You may not qualify if:
- BMI \<25 or \>35;
- Severely depressed (Beck's Depression Inventory score \>30);
- Total cholesterol \>240 mg/dL, low-density lipoprotein cholesterol \>160 mg/dL, triglycerides \>400 mg/dL, fasting glucose \>110 mg/dL;
- Body weight changes in previous 3 months (±3 kg);
- Changes in physical activity regimen in the previous 3 months;
- Medication changes in the previous 6 months;
- Smoking;
- Diabetic;
- Acute illness;
- Pregnant or lactating;
- Allergic to mushrooms
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Purdue Universitylead
- Mushroom Councilcollaborator
Study Sites (1)
Purdue University
West Lafayette, Indiana, 47906, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Wayne Campbell, PhD
Purdue University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 18, 2019
First Posted
February 5, 2020
Study Start
August 15, 2020
Primary Completion
May 21, 2021
Study Completion
May 21, 2021
Last Updated
February 16, 2024
Record last verified: 2024-02